Total necrosis after sequential treatment with pazopanib followed by nivolumab in a patient with renal cell carcinoma involving the inferior vena cava

Int J Urol. 2019 Feb;26(2):313-314. doi: 10.1111/iju.13853. Epub 2018 Nov 14.

Authors

Yusuke Shiraishi¹, Tomoaki Terakawa¹, Naoe Jimbo², Katsumi Shigemura¹, Nobuyuki Hinata¹, Masato Fujisawa¹

Affiliations

¹ Department of Urology, Kobe University Graduate School of Medicine, Kobe, Hyogo, Japan.
² Department of Pathology, Kobe University Graduate School of Medicine, Kobe, Hyogo, Japan.

PMID: 30430647
DOI: 10.1111/iju.13853

No abstract available

Publication types

Case Reports

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / pharmacology
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Carcinoma, Renal Cell / diagnostic imaging
Carcinoma, Renal Cell / pathology
Carcinoma, Renal Cell / therapy*
Humans
Indazoles
Kidney / diagnostic imaging
Kidney / pathology
Kidney / surgery
Kidney Neoplasms / diagnostic imaging
Kidney Neoplasms / pathology
Kidney Neoplasms / therapy*
Necrosis / chemically induced
Necrosis / diagnostic imaging
Neoadjuvant Therapy / methods
Neoplasm Invasiveness / diagnostic imaging
Neoplasm Invasiveness / pathology
Nephrectomy
Nivolumab / pharmacology
Nivolumab / therapeutic use
Pyrimidines / pharmacology
Pyrimidines / therapeutic use
Sulfonamides / pharmacology
Sulfonamides / therapeutic use
Tomography, X-Ray Computed
Treatment Outcome
Vena Cava, Inferior / diagnostic imaging
Vena Cava, Inferior / pathology*
Vena Cava, Inferior / surgery

Substances

Indazoles
Pyrimidines
Sulfonamides
Nivolumab
pazopanib